Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1,295 breast cancer cases

Human Pathology

Volumn 27, Issue 6, 1996, Pages 553-560

  Bergers, Elisabeth ^b   Montironi, Rodolfo ^b   Van Diest, Paul J ^b   Prete, Elisabetta ^b   Baak, Jan P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

breast cancer; cell cycle analysis; DNA histograms; flow cytometry; reproducibility

Indexed keywords

ARTICLE; BREAST CANCER; CELL CYCLE PHASE; CELL SUSPENSION; CLINICAL TRIAL; DNA CONTENT; FEMALE; FLOW CYTOMETRY; FROZEN SECTION; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PLOIDY; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY;

EID: 0030000078     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90161-6     Document Type: Article

References (30)

1. Dressler LG, Seamer LC, Owens MA, et al: DNA-flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61:420-427, 1988
2. Kallioniemi OP, Blanco G, Alavaikko M, et al: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 62:2183-2190, 1988
3. Muss HB, Kute TE, Case LD, et al: The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 64:1894-1900, 1989
4. Uyterlinde AM, Schipper NW, Baak JPA: Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer. J Clin Pathol 40:1432-1436, 1987
5. Uyterlinde AM, Schipper NW, Baak JPA, et al: Limited prognostic value of cellular DNA-content to classical and morphometrical parameters in invasive ductal breast cancer. Am J Clin Pathol 89:301-307, 1988
6. Baildam AD, Zaloudik J, Howell A, et al: DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer 55:553-559, 1987
7. Keyhani-Rofagha S, O'Toole RV, Farrar WB, et al: Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma? Cancer 65:1577-1582, 1990
8. O'Reilly SM, Camplejohn RS, Barnes DM, et al: DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 61:671-674, 1990
9. Bonsing BA, Beerman H, Kuipers-Dijkshoorn N, et al: High levels of DNA Index heterogeneity in advanced breast cancer. Cancer 71:382-391, 1993
10. Kute TE, Gregory B, Galleshaw J, et al: How reproducible are flow cytometry data from paraffin-embedded blocks? Cytometry 9:494-498, 1988
11. Coon SC, Paxton H, Lucy L, et al: Interlaboratory variation in DNA flow cytometry. Arch Pathol Lab Med 118:681-685, 1994
12. Coon J, Deitch AD, Vere White RW de, et al: Interinstitutional variability in DNA flow cytometric analysis of tumors. Cancer 61:126-130, 1988
13. Danesi DT, Spano M, Altavista P: Quality control study of the italian group of cytometry on flow cytometry cellular DNA content measurements. Cytometry 14:576-583, 1993
14. Fosså SD, Berner A, Waehre H, et al: DNA ploidy in cell nuclei from paraffin-embedded material: Comparison of results from two laboratories. Cytometry 13:395-403, 1992
15. van Thiel PH, van der Linden JC, Baak JPA, et al: Reproducibility of flow cytometric assessment of follicular tumours of the thyroid. J Clin Pathol 42:260-263, 1989
16. Wheeless LL, Coon JS, Cox C, et al: Precision of DNA flow cytometry in inter-institutional analysis. Cytometry 12:405-412, 1991
17. Wheeless LL, Coon JS, Cox C, et al: Measurement variability in DNA flow cytometry of replicate samples. Cytometry 10:731-738, 1989
18. Uyterlinde AM, Smeulders AWM, Baak JPA: Reproducibility and comparison of quantitative DNA histogram features obtained with a scanning microdensitometer and a flow cytometer in breast cancer. Anal Quant Cytol Histol 11:353-360, 1988
19. Ferrero M, Spyratos F, le Doussal V, et al: Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. Cytometry 11:716-724, 1990
20. Zarbo RJ, Visscher DW, Crissman JD: Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 11:391-402, 1989
21. Joensuu H, Kallioniemi OP: Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry 10:711-717, 1989
22. Silvestrini, and the SICCAB group for quality control of cell kinetic determinations, et al: Quality control for evaluation of the S-phase fraction by flow cytometry: A multicentric study. Cytometry 18:11-16, 1994
23. Bergers E, van Diest PJ, Baak JPA: Reproducibility of semiautomated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material. Anal Cell Pathol 8:1-13, 1995
24. Baak JPA, van Diest PJ, Ariens AT, et al: The Multicenter Morphometric Mammary Carcinoma Project (MMMCP): A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands. Pathol Res Pract 185:644-670, 1989
25. Vindelov LL, Christensen IJ, Nisses NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometiy 3:323-327, 1983a
26. Rabinovitch PS: Practical considerations for DNA-content and cell cycle analysis, in Bauer KD, Duque RE, Shankey TV (eds): Clinical Flow Cytometry: Principles and Applications. Baltimore, MD, Williams & Wilkins, 1993, pp 117-143
27. Kallioniemi OP, Visakorpi T, Holli K, et al: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 12:413-421, 1991
28. Homburger HA, McCarthy R, Deodhar S: Assessment of interlaboratory variability in analytical cytology. Arch Pathol Lab Med 113:667-672, 1989
29. van Diest PJ, Baak JPA, Matze-Cok P, et al: Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma Project. HUM PATHOL 23:603-607, 1992
30. Shankey TV, Rabinovitch PS, Bagwell B, et al: Guidelines for implementation of clinical DNA cytometry. Cytometry 14:472-477, 1993